Effectiveness of methyl-GAG (NSC-32946) administered intramuscularly

Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):689-95.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Aldehydes / therapeutic use*
  • Amidines / administration & dosage
  • Amidines / adverse effects
  • Amidines / therapeutic use*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Evaluation
  • Feeding and Eating Disorders / chemically induced
  • Female
  • Glyoxal / administration & dosage
  • Glyoxal / adverse effects
  • Glyoxal / therapeutic use*
  • Humans
  • Hydrazones / administration & dosage
  • Hydrazones / adverse effects
  • Hydrazones / therapeutic use
  • Injections, Intramuscular
  • Injections, Intravenous
  • Male
  • Neoplasms / drug therapy*
  • Skin Manifestations

Substances

  • Aldehydes
  • Amidines
  • Antineoplastic Agents
  • Hydrazones
  • Glyoxal